Joshua Bowling, MD
Sleep Medicine · Mishawaka, INNPI 1750744223
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,840 of the $3,185 with a category attached, or 89.2%. 8 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 58.1% of the total. 2025 is the largest year on record at $1,314, more than ten times the $22 reported in 2022.
Across 168 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Jazz Pharmaceuticals Inc.$612
- Harmony Biosciences LLC$515
- AbbVie$125
- Avadel CNS Pharmaceuticals, LLC$30
- Novo Nordisk$19
- plus $33 from 2 others
What the payments were for
- Food & beverage$2,84089%
- Education$34511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 116 | $1,850 |
| Jazz Pharmaceuticals Inc. | 15 | $612 |
| Harmony Biosciences LLC | 31 | $515 |
| AbbVie | 1 | $125 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $30 |
| Novo Nordisk | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,185 in reported general payments places this provider in the 70th percentile of 32 sleep medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 37 | $7,394 |
| Hydroxyzine Hcl | 34 | $700 |
| Gabapentin | 76 | $629 |
| Doxepin Hcl | 27 | $544 |
| Trazodone Hcl | 84 | $476 |
| Eszopiclone | 16 | $316 |
| Pregabalin | 20 | $309 |
| Ropinirole Hcl | 31 | $264 |
| Zolpidem Tartrate ErZolpidem Tartrate | 24 | $172 |
| Zolpidem Tartrate | 30 | $83 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Mishawaka
- Shalini ManchandaIndianapolis$43K
- Aaron RobertsFort Wayne$31K
- Sridhar JatlaKokomo$10K
- Douglas LiepertSouth Bend$10K
- Israr SiddiqiElkhart$8K
- Adam LenetIndianapolis$5K
- Alaa ShammahIndianapolis$3K
- Akudo AnokwuteBrownsburg$3K
- Ram VermaFort Wayne$3K
- Emilee SurvanceSeymour$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.